1. Home
  2. ALUR vs PCLA Comparison

ALUR vs PCLA Comparison

Compare ALUR & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALUR
  • PCLA
  • Stock Information
  • Founded
  • ALUR 2009
  • PCLA 2008
  • Country
  • ALUR United States
  • PCLA Japan
  • Employees
  • ALUR N/A
  • PCLA N/A
  • Industry
  • ALUR
  • PCLA Building Products
  • Sector
  • ALUR
  • PCLA Consumer Discretionary
  • Exchange
  • ALUR Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • ALUR 16.8M
  • PCLA 16.9M
  • IPO Year
  • ALUR N/A
  • PCLA 2025
  • Fundamental
  • Price
  • ALUR $2.14
  • PCLA $0.54
  • Analyst Decision
  • ALUR Strong Buy
  • PCLA
  • Analyst Count
  • ALUR 3
  • PCLA 0
  • Target Price
  • ALUR $22.83
  • PCLA N/A
  • AVG Volume (30 Days)
  • ALUR 52.4K
  • PCLA 207.4K
  • Earning Date
  • ALUR 11-12-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • ALUR N/A
  • PCLA N/A
  • EPS Growth
  • ALUR N/A
  • PCLA N/A
  • EPS
  • ALUR N/A
  • PCLA N/A
  • Revenue
  • ALUR $19,917,000.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • ALUR N/A
  • PCLA N/A
  • Revenue Next Year
  • ALUR $168.27
  • PCLA N/A
  • P/E Ratio
  • ALUR N/A
  • PCLA N/A
  • Revenue Growth
  • ALUR N/A
  • PCLA 40.19
  • 52 Week Low
  • ALUR $1.98
  • PCLA $0.37
  • 52 Week High
  • ALUR $20.00
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • ALUR 40.16
  • PCLA 50.64
  • Support Level
  • ALUR $2.10
  • PCLA $0.42
  • Resistance Level
  • ALUR $2.22
  • PCLA $0.53
  • Average True Range (ATR)
  • ALUR 0.11
  • PCLA 0.04
  • MACD
  • ALUR 0.02
  • PCLA 0.03
  • Stochastic Oscillator
  • ALUR 40.74
  • PCLA 100.00

About ALUR Allurion Technologies Inc.

Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: